price_targets,,2019-05-24 15:50:00,18.942,FATE trades at 18965 7 analysts have a high PT of 2600 and a low PT of 1900 2186 is the avg blueequityiosymbolFATEP
MariaC82,,2019-05-24 12:35:00,18.68,Upgrades Downgrades Initiations More 2 APHA FATE ADSK SPLK DECK
Capitaltryst,,2019-05-24 10:35:00,18.91,FATE MRKR GILD ATRA Long term the cell therapy sector has an incredible amount going for it In addition to already having 800lb gorillas potcommitted to the space I believe that the highmoat platform bioengineering aspects of cell therapy will become a bulwark against the rising tide of populist outrage aimed at pharmaceutical pricing and drug co profits When I think about what cell therapy could become in 30 years as we become ever more adept at manipulating these mini machines my mind boggles My current positions are ATRA FATE shares and short puts MRKR shares and short puts and GILD shares and short puts
AnalystRatingsNetwork,,2019-05-24 10:14:00,19.11,Fate Therapeutics initiated by Citigroup Inc at buy 2600 PT marketbeatcomstocksNASDA FATE
